TRAX

First Tracks Biotherapeutics Inc NASDAQ Listed Apr 20, 2026

Healthcare ·Biotechnology ·US

$41.90

-7.91% vs $45.50

Mkt Cap $1.5B

52w Low $14.72 77.2% of range 52w High $49.91

50d MA $32.52 200d MA $26.14

P/E (TTM) —

EV/EBITDA —

P/B —

Debt/Equity —

ROE —

P/FCF —

RSI (14) 43.80

ATR (14) $3.20

Beta 0.00

50d MA $32.52

200d MA $26.14

Avg Volume 773.0K

First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.

SIC Code

2834

CIK (SEC)

2091349

Phone

212-373-3000

10770 WATERIDGE CIRCLE · San Diego, CA 92121 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Aug 12, 2026	AMC	-0.74	-0.95	-28.4%	46.13	+0.0%	-4.6%	+0.0%	-1.0%	+0.6%	+3.7%	—
Aug 11, 2026	AMC	-0.74	-0.95	-28.4%	46.75	-0.4%	-1.3%	-4.6%	+0.0%	-1.0%	+0.6%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Aug 18	Wolfe Research	Initiates	Outperform	$83	$43.60	$43.76	+0.4%	+0.6%	+3.7%	—	—	—
Jun 8	Wells Fargo	Initiates	Overweight	$30	$16.60	$17.08	+2.9%	-5.1%	+1.4%	+2.8%	+3.7%	+3.6%
May 4	Piper Sandler	Initiates	Overweight	$54	$22.38	$21.52	-3.8%	-8.2%	+3.1%	-4.4%	-12.0%	+9.7%
Apr 28	H.C. Wainwright	Initiates	Buy	$30	$18.10	$17.44	-3.6%	+10.8%	+17.9%	-1.6%	-3.8%	-8.2%
Apr 24	Leerink Partners	Initiates	Outperform	$46	$19.00	$20.20	+6.3%	-4.4%	-0.3%	+10.8%	+17.9%	-1.6%
Apr 24	Wedbush	Initiates	Outperform	$30	$19.00	$20.20	+6.3%	-4.4%	-0.3%	+10.8%	+17.9%	-1.6%
Apr 23	JP Morgan	Initiates	Overweight	$31	$18.87	$18.99	+0.6%	+0.7%	-4.4%	-0.3%	+10.8%	+17.9%
Apr 22	Barclays	Initiates	Overweight	$40	$17.00	$17.65	+3.8%	+11.0%	+0.7%	-4.4%	-0.3%	+10.8%
Apr 21	UBS	Initiates	Buy	$45	$18.60	$18.05	-3.0%	-8.6%	+11.0%	+0.7%	-4.4%	-0.3%

Institutional (13F) — Top 0 All ↗

No 13F holders found.

Mutual Funds / ETFs (N-PORT) — Top 1 All ↗

#	Fund	Shares	Value	Period
1	Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF	7,749	$124K	May 2026

Data updated apr 27, 2026 5:29am · Source: financialmodelingprep.com